Companies / Creative Biolabs / Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (CrossMab)
Creative Biolabs

Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (CrossMab) | Creative Biolabs

Recombinant Anti-CD133 x Anti-EGFR Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can target brain tumor stem cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.

Reviews


No reviews yet

ABOUT THE COMPANY

Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields. 

  • See More